INHIBRX BIOSCIENCES, INC. (INBX) Total liabilities 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) total liabilities at each fiscal year-end, per SEC filings.
$138.5MFY2025 · since FY2023: $264.4M → $138.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $138.5M | +193.5% |
| FY2024 | $47.2M | -82.2% |
| FY2023 | $264.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More INBX financial trends
INBX RevenueINBX Net incomeINBX Net marginINBX Gross profitINBX Gross marginINBX Operating incomeINBX Operating marginINBX Operating cash flowINBX Free cash flowINBX Capital expendituresINBX Return on equityINBX Stock buybacksINBX Dividends paidINBX Total assetsINBX Shareholders’ equityINBX overview →